Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1955 1
1965 1
1978 1
1981 1
1986 2
1988 2
1989 3
1990 5
1991 7
1992 4
1993 7
1994 5
1995 7
1996 7
1997 11
1998 8
1999 7
2000 11
2001 4
2002 11
2003 10
2004 9
2005 13
2006 9
2007 6
2008 12
2009 6
2010 9
2011 11
2012 7
2013 12
2014 24
2015 28
2016 21
2017 26
2018 24
2019 34
2020 37
2021 30
2022 36
2023 27
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

445 results

Results by year

Filters applied: . Clear all
Page 1
A randomised phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer (JCOG1407).
Ozaka M, Nakachi K, Kobayashi S, Ohba A, Imaoka H, Terashima T, Ishii H, Mizusawa J, Katayama H, Kataoka T, Okusaka T, Ikeda M, Sasahira N, Miwa H, Mizukoshi E, Okano N, Mizuno N, Yamamoto T, Komatsu Y, Todaka A, Kamata K, Furukawa M, Fujimori N, Katanuma A, Takayama Y, Tsumura H, Fukuda H, Ueno M, Furuse J; Hepatobiliary and Pancreatic Oncology Group of Japan Clinical Oncology Group (JCOG). Ozaka M, et al. Among authors: tsumura h. Eur J Cancer. 2023 Mar;181:135-144. doi: 10.1016/j.ejca.2022.12.014. Epub 2022 Dec 27. Eur J Cancer. 2023. PMID: 36652891 Free article. Clinical Trial.
Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial.
Kudo M, Ueshima K, Ikeda M, Torimura T, Tanabe N, Aikata H, Izumi N, Yamasaki T, Nojiri S, Hino K, Tsumura H, Kuzuya T, Isoda N, Yasui K, Aino H, Ido A, Kawabe N, Nakao K, Wada Y, Yokosuka O, Yoshimura K, Okusaka T, Furuse J, Kokudo N, Okita K, Johnson PJ, Arai Y; TACTICS study group. Kudo M, et al. Among authors: tsumura h. Gut. 2020 Aug;69(8):1492-1501. doi: 10.1136/gutjnl-2019-318934. Epub 2019 Dec 4. Gut. 2020. PMID: 31801872 Free PMC article. Clinical Trial.
Relationships between Slc1a5 and Osteoclastogenesis.
Tsumura H, Shindo M, Ito M, Igarashi A, Takeda K, Matsumoto K, Ohkura T, Miyado K, Sugiyama F, Umezawa A, Ito Y. Tsumura H, et al. Comp Med. 2021 Aug 1;71(4):285-294. doi: 10.30802/AALAS-CM-21-000012. Epub 2021 Jun 28. Comp Med. 2021. PMID: 34301346 Free PMC article.
Inguinal hernia associated with radical prostatectomy.
Nagatani S, Tsumura H, Kanehiro T, Yamaoka H, Kameda Y. Nagatani S, et al. Among authors: tsumura h. Surg Today. 2021 May;51(5):792-797. doi: 10.1007/s00595-020-02146-9. Epub 2020 Sep 26. Surg Today. 2021. PMID: 32979120
445 results